What is it about?
With the advent of highly effective plant-based medications with few or no side effects, the use of phytomedicines against complex diseases such as cancer is becoming more widespread. The broadly recognized pentacyclic triterpenes known as boswellic acids (BAs) are derived from the oleogum resin, or frankincense, extracted from the plant species of the genus Boswellia. The frankincense mixture contains various BA types, each having a different potential and helping treat certain cancers.
Featured Image
Photo by Chinh Le Duc on Unsplash
Why is it important?
This review focuses on details regarding the traits of the BAs, their roles as anti-cancer agents, the mechanism underlying their activities, and the function of their semi-synthetic derivatives in managing and treating certain cancers.
Perspectives
The review concludes that the BAs and their semi-synthetic derivatives are effective against a broad spectrum of cancer cell lines. The detailed information in the review can be helpful for researchers to gain more information about BAs and BA-based medications for efficient and cost-effective cancer treatments.
habilitated doctor, chemist Monica BUTNARIU
University of Life Sciences "King Mihai I" from Timisoara
Read the Original
This page is a summary of: Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent, Frontiers in Pharmacology, August 2023, Frontiers,
DOI: 10.3389/fphar.2023.1187181.
You can read the full text:
Contributors
The following have contributed to this page
